ICU Medical, Inc. (ICUI) Tops Q2 EPS by 11c, Raises FY11 Guidance
Tweet
Share
E-mailGet Alerts ICUI Hot Sheet
Price: $96.37 -0.75%
EPS Growth %: +319.5%
Financial Fact:
Income from operations: 22.46M
Today's EPS Names:
MFON, SICP, LBAS, More
EPS Growth %: +319.5%
Financial Fact:
Income from operations: 22.46M
Today's EPS Names:
MFON, SICP, LBAS, More
Join SI Premium – FREE
ICU Medical, Inc. (NASDAQ: ICUI) reported Q2 EPS of $0.67, $0.11 better than the analyst estimate of $0.56. Revenue for the quarter came in at $77.8 million versus the consensus estimate of $74.24 million.
The company raised its FY11 revenue guidance to $297 million to $305 million, compared to its previous range of $295 million to $305 million. The Street is currently looking for $306.7 million.
The company also raised its FY11 EPS range to $2.35 to $2.50 per share, compared to its previous range of $2.30 to $2.50 per share. The consensus is $2.45.
Operating cash flow is expected to be in the range of $45 million to $50 million.
The company raised its FY11 revenue guidance to $297 million to $305 million, compared to its previous range of $295 million to $305 million. The Street is currently looking for $306.7 million.
The company also raised its FY11 EPS range to $2.35 to $2.50 per share, compared to its previous range of $2.30 to $2.50 per share. The consensus is $2.45.
Operating cash flow is expected to be in the range of $45 million to $50 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adidas (ADDYY) gains after outlook boost
- TScan Therapeutics, Inc (TCRX) Provides Clinical Pipeline Update, Highlights Near-Term Priorities
- Interactive Brokers (IBKR) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
